Related content

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 442-448

Science Publishers

Access to resources Recommend Favorite

Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I-II clinical trial

By Wu K.-L.   Jiang G.-L.   Qian H.   Wang L.-J.   Yang H.-J.   Fu X.-L.   Zhao S.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1345-1350

Elsevier

Access to resources Recommend Favorite

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

By Cheng Jing  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi   Araki Tsutomu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite